3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. (September 2015) - Tamiya, A.; Yoshioka, H.; Nishimura, T.; Iwamoto, Y.; Kim, Y.H.; Tomii, K.; Katakami, N.; Komuta, K.; Nishikawa, M.; Yamaki, K.; Gemma, A.; Kawahara, M.; et al.